Screener
Kailera Therapeutics KLRA Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q1 '25 | ||
|---|---|---|---|---|
| $111.83M+9.9% | $160.27M— | $101.78M— | ||
| $407.35M— | $385.79M— | —— | ||
| $530.32M— | $557.54M— | —— | ||
| $1.85M— | $1.96M— | —— | ||
| $624.76M— | $692.29M— | —— | ||
| $7.1M+1,000% | $7.53M— | $645K— | ||
| $54.84M— | $46.41M— | —— | ||
| $64.48M— | $56.39M— | —— | ||
| $0— | $0— | —— | ||
| -$447.53M— | -$368.67M— | —— | ||
| -$432.09M-83.7% | -$356.46M-62.9% | -$235.24M— | ||
| $624.76M— | $692.29M— | —— |
FAQ
- What are Kailera Therapeutics's total assets?
- Kailera Therapeutics (KLRA) holds $624.8M in total assets.
- How much debt does Kailera Therapeutics have?
- Kailera Therapeutics carries $10.5M in total debt against -$432.1M of shareholders' equity, a debt-to-equity ratio of -0.02.
- How much cash does Kailera Therapeutics have?
- Kailera Therapeutics holds $111.8M in cash and equivalents.
- Can Kailera Therapeutics cover its short-term obligations?
- Its current ratio is 9.67 — current assets exceed current liabilities.
- Where does Kailera Therapeutics's balance sheet data come from?
- Every line is extracted from Kailera Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.